Stryker Corp Dossier - Source-backed chat

Stryker Corp

SYKNYSE

SectorHealth Care

IndustryHealth Care Equipment

Beta (adjusted)0.84

Intrinsic Value $366.05median of 6 methods · middle span $312-$417based on filings through 30 Jun 2026

Market Price $272.96Price as of 1 Oct 2026

UndervaluedIntrinsic value is 34% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $104.7B

Enterprise Value $116.3B

Shares Outstanding 386.3M diluted

Moat Rating Wide

Next Earnings Date29 Oct 2026

Last ex-dividend30 Sep 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Stryker's second-quarter recovery supports a constructive operating outlook: organic sales grew 9.0%, adjusted diluted EPS increased to $3.69 and adjusted operating margin reached 27.4%. Management narrowed FY2026 organic-growth guidance to 8.3%-9.3% and adjusted-EPS guidance to $14.95-$15.10. A Hold stance therefore balances strong operating momentum against incomplete admissible valuation evidence and the execution risk exposed by the first-quarter cybersecurity disruption.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets25 analysts · as of 18 Aug 2026

Low · most bearish analyst$315.00

Mean target$382.88

High · most bullish analyst$465.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$315.0020%

Organic growth falls below 8.3% or adjusted EPS falls below $14.95 because recovery proves incomplete, operational disruption recurs or margins surrender part of the second-quarter improvement.

Base CaseCentral scenario

$382.8855%

Matches the consensus mean

Stryker finishes FY2026 within its 8.3%-9.3% organic-sales range and $14.95-$15.10 adjusted-EPS range, with continued operating leverage following the second-quarter recovery.

Bull CaseUpside scenario

$465.0025%

Organic growth exceeds the 9.3% upper end of FY2026 guidance, adjusted EPS exceeds $15.10 and the second quarter's margin improvement proves durable as delayed demand is recovered.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Second-quarter 2026 organic net sales increased 9.0%, while reported net sales rose 9.4% to approximately $6.6 billion.
Second-quarter adjusted diluted EPS increased 17.9% to $3.69, and adjusted operating income margin expanded 170 basis points to 27.4%.
Management's narrowed FY2026 outlook calls for 8.3%-9.3% organic growth and adjusted diluted EPS of $14.95-$15.10.

Key Investment Risks

The first-quarter cybersecurity disruption demonstrated operating sensitivity: first-quarter organic growth was 2.4% and adjusted EPS declined 8.5% to $2.60 before the second-quarter recovery.
Achieving full-year guidance requires sustained execution after the weak first quarter; a renewed disruption or slower recovery could push organic growth or adjusted EPS below the published ranges.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.